Abstract:Complex genetic and physiological variations as well as environmental factors that drive emergence of chromosomal instability, development of unscheduled cell death, skewed differentiation, and altered metabolism are central to the pathogenesis of human diseases and disorders. Understanding the molecular bases for these processes is important for the development of new diagnostic biomarkers, and for identifying new therapeutic targets. In 1973, a group of non-histone nuclear proteins with high electrophoretic mobility was discovered and termed high-mobility group (HMG) proteins. The HMG proteins include three superfamilies termed HMGB, HMGN, and HMGA. High-mobility group box 1 (HMGB1), the most abundant and well-studied HMG protein, senses and coordinates the cellular stress response and plays a critical role not only inside of the cell as a DNA chaperone, chromosome guardian, autophagy sustainer, and protector from apoptotic cell death, but also outside the cell as the prototypic damage associated molecular pattern molecule (DAMP). This DAMP, in conjunction with other factors, thus has cytokine, chemokine, and growth factor activity, orchestrating the inflammatory and immune response. All of these characteristics make HMGB1 a critical molecular target in multiple human diseases including infectious diseases, ischemia, immune disorders, neurodegenerative diseases, metabolic disorders, and cancer. Indeed, a number of emergent strategies have been used to inhibit HMGB1 expression, release, and activity in vitro and in vivo. These include antibodies, peptide inhibitors, RNAi, anti-coagulants, endogenous hormones, various chemical compounds, HMGB1-receptor and signaling pathway inhibition, artificial DNAs, physical strategies including vagus nerve stimulation and other surgical approaches. Future work further investigating the details of HMGB1 localization, structure, post-translational modification, and identification of additional partners will undoubtedly uncover additional secrets regarding HMGB1's multiple functions.

Revealing the extracellular function of HMGB1 N-terminal region acetylation assisted by a protein semi-synthesis approach

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

The mechanism of HMGB1 secretion and release

HMGB1 as a therapeutic target in disease

The multifunctional protein HMGB1: 50 years of discovery

Phosphorylation-regulated HMGA1a-P53 interaction unveils the function of HMGA1a acidic tail phosphorylations via synthetic proteins

Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation

HMGB1 in health and disease

Targeting Inflammation Driven by HMGB1

Integrative Proteomic Analysis of Posttranslational Modification in the Inflammatory Response

Post-translational Modifications by Acyl Groups Regulate FEN1's Activities and Play Essential Roles in Cell Proliferation and DNA Repair

Integrative Proteomic Analysis of Multiple Posttranslational Modifications in Inflammatory Response

Activation of Toll-Like Receptor 5 Immune Signaling by Hmgb1

HMGB1 as a DNA-binding cytokine

Abstract P286: Acetylation Affords Enhanced Proteolytic Function in Normal and Diseased Myocardium

Characterization of diverse non-covalent interactions associated with protein acetylation.

Deciphering HMGB1: Across a spectrum of DNA and nucleosome dynamics

Redox modifications of cysteine residues regulate the cytokine activity of HMGB1

HMGB1 restores a dynamic chromatin environment in the presence of linker histone by deforming nucleosomal DNA

HMGB1, a novel inflammatory cytokine

[Role of HMGB1 in Rheumatic Diseases].